Jerry N. Karabelas
Argeris (Jerry) N. Karabelas is Chairman of the Board of Human Genome Sciences "and a member of the Compensation Committee. He has been a partner of Care Capital LLC since 2001 and was the Founder and Chairman of Novartis BioVenture Fund from 2000 to 2001. Dr. Karabelas was also the Head of Healthcare and CEO of Worldwide Pharmaceuticals at Novartis, AG from 1998 to 2000; Executive Vice President, Pharmaceuticals, at SmithKline Beecham from 1997 to 1998; President, North American Pharmaceuticals, at SmithKline Beecham from 1993 to 1997; and Vice President, U.S. Marketing, at SmithKline Beecham from 1990 to 1993. Dr. Karabelas is a Visiting Committee Member of MIT Health Studies & Technology, Director of SkyePharma PLC, Chairman of Nitromed, Inc., Director of Cyreniac Pharmaceutical, Director of Minster Pharmaceuticals plc; Director of Renovo PLC, Chairman of Vanda Pharmaceuticals Inc. and Chairman of Inotek, Inc." 
Resources and articles
Related Sourcewatch articles
- Directors, Human Genome Sciences, accessed January 5, 2009.